Tags

Type your tag names separated by a space and hit enter

Coenzyme Q10 treatment in serious heart failure.
Biofactors 1999; 9(2-4):285-9B

Abstract

Several noninvasive studies have shown the effect on heart failure of treatment with coenzyme Q10. In order to confirm this by invasive methods we studied 22 patients with mean left ventricular (LV) ejection fraction 26%, mean LV internal diameter 71 mm and in NYHA class 2-3. The patients received coenzyme Q10 100 mg twice daily or placebo for 12 weeks in a randomized double-blinded placebo controlled investigation. Before and after the treatment period, a right heart catheterisation was done including a 3 minute exercise test. The stroke index at rest and work improved significantly, the pulmonary artery pressure at rest and work decreased (significantly at rest), and the pulmonary capillary wedge pressure at rest and work decreased (significantly at 1 min work). These results suggest improvement in LV performance. Patients with congestive heart failure may thus benefit from adjunctive treatment with coenzyme Q10.

Authors+Show Affiliations

Dept. of Cardiology, Aalborg Hospital, Denmark.

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

10416042

Citation

Munkholm, H, et al. "Coenzyme Q10 Treatment in Serious Heart Failure." BioFactors (Oxford, England), vol. 9, no. 2-4, 1999, pp. 285-9.
Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Biofactors. 1999;9(2-4):285-9.
Munkholm, H., Hansen, H. H., & Rasmussen, K. (1999). Coenzyme Q10 treatment in serious heart failure. BioFactors (Oxford, England), 9(2-4), pp. 285-9.
Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 Treatment in Serious Heart Failure. Biofactors. 1999;9(2-4):285-9. PubMed PMID: 10416042.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coenzyme Q10 treatment in serious heart failure. AU - Munkholm,H, AU - Hansen,H H, AU - Rasmussen,K, PY - 1999/7/23/pubmed PY - 1999/7/23/medline PY - 1999/7/23/entrez SP - 285 EP - 9 JF - BioFactors (Oxford, England) JO - Biofactors VL - 9 IS - 2-4 N2 - Several noninvasive studies have shown the effect on heart failure of treatment with coenzyme Q10. In order to confirm this by invasive methods we studied 22 patients with mean left ventricular (LV) ejection fraction 26%, mean LV internal diameter 71 mm and in NYHA class 2-3. The patients received coenzyme Q10 100 mg twice daily or placebo for 12 weeks in a randomized double-blinded placebo controlled investigation. Before and after the treatment period, a right heart catheterisation was done including a 3 minute exercise test. The stroke index at rest and work improved significantly, the pulmonary artery pressure at rest and work decreased (significantly at rest), and the pulmonary capillary wedge pressure at rest and work decreased (significantly at 1 min work). These results suggest improvement in LV performance. Patients with congestive heart failure may thus benefit from adjunctive treatment with coenzyme Q10. SN - 0951-6433 UR - https://www.unboundmedicine.com/medline/citation/10416042/Coenzyme_Q10_treatment_in_serious_heart_failure_ L2 - https://content.iospress.com/openurl?genre=article&issn=0951-6433&volume=9&issue=2-4&spage=285 DB - PRIME DP - Unbound Medicine ER -